Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 528-533

  Song, Mee Hyun ^a,b   Choi, Soo Young ^c   Wu, Ling ^b   Oh, Se Kyoung ^c   Lee, Hee Keun ^c   Lee, Dong Jin ^b   Shim, Dae Bo ^a,b   Choi, Jae Young ^b   Kim, Un Kyung ^c   Bok, Jinwoong ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

DFN3; Hearing loss; Pou3f4; Transcription factor

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR4.1; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR POU3F4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE COURSE; EAR; FIBROBLAST; GENE EXPRESSION; HEARING LOSS; HISTOPATHOLOGY; MESENCHYME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SOUND TRANSMISSION; SPIRAL LIGAMENT; STRIA VASCULARIS; X CHROMOSOME LINKED DISORDER; X LINKED DEAFNESS TYPE 3;

ANIMALS; CRYSTALLINS; DISEASE MODELS, ANIMAL; EAR, INNER; GENE EXPRESSION; HEARING LOSS, SENSORINEURAL; MESODERM; MICE; NERVE TISSUE PROTEINS; POU DOMAIN FACTORS; SPIRAL LIGAMENT OF COCHLEA; STRIA VASCULARIS;

MUS;

EID: 78650865130     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.019     Document Type: Article

References (28)

1. de Kok Y.J., van der Maarel S.M., Bitner-Glindzicz M., Huber I., Monaco A.P., Malcolm S., Pembrey M.E., Ropers H.H., Cremers F.P. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995, 267:685-688.
2. Petersen M.B., Wang Q., Willems P.J. Sex-linked deafness. Clin. Genet. 2008, 73:14-23.
3. Lee H.K., Song M.H., Kang M., Lee J.T., Kong K.A., Choi S.J., Lee K.Y., Venselaar H., Vriend G., Lee W.S., Park H.J., Kwon T.K., Bok J., Kim U.K. Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein. Physiol. Genom. 2009, 39:195-201.
4. Trowe M.O., Maier H., Schweizer M., Kispert A. Deafness in mice lacking the T-box transcription factor Tbx18 in otic fibrocytes. Development 2008, 135:1725-1734.
5. Spicer S.S., Schulte B.A. Differentiation of inner ear fibrocytes according to their ion transport related activity. Hear Res. 1991, 56:53-64.
6. Kikuchi T., Adams J.C., Miyabe Y., So E., Kobayashi T. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness. Med. Electron. Microsc. 2000, 33:51-56.
7. Minowa O., Ikeda K., Sugitani Y., Oshima T., Nakai S., Katori Y., Suzuki M., Furukawa M., Kawase T., Zheng Y., Ogura M., Asada Y., Watanabe K., Yamanaka H., Gotoh S., Nishi-Takeshima M., Sugimoto T., Kikuchi T., Takasaka T., Noda T. Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science 1999, 285:1408-1411.
8. Phippard D., Lu L., Lee D., Saunders J.C., Crenshaw E.B. Targeted mutagenesis of the POU-domain gene Brn4/Pou3f4 causes developmental defects in the inner ear. J. Neurosci. 1999, 19:5980-5989.
9. Phippard D., Boyd Y., Reed V., Fisher G., Masson W.K., Evans E.P., Saunders J.C., Crenshaw E.B. The sex-linked fidget mutation abolishes Brn4/Pou3f4 gene expression in the embryonic inner ear. Hum. Mol. Genet. 2000, 9:79-85.
10. Braunstein E.M., Crenshaw E.B., Morrow B.E., Adams J.C. Cooperative function of Tbx1 and Brn4 in the periotic mesenchyme is necessary for cochlea formation. J. Assoc. Res. Otolaryngol. 2008, 9:33-43.
11. Xia A.P., Kikuchi T., Minowa O., Katori Y., Oshima T., Noda T., Ikeda K. Late-onset hearing loss in a mouse model of DFN3 non-syndromic deafness: morphologic and immunohistochemical analyses. Hear. Res. 2002, 166:150-158.
12. Wang X.H., Streeter M., Liu Y.P., Zhao H.B. Identification and characterization of pannexin expression in the mammalian cochlea. J. Comp. Neurol. 2009, 512:336-346.
13. Morsli H., Choo D., Ryan A., Johnson R., Wu D.K. Development of the mouse inner ear and origin of its sensory organs. J. Neurosci. 1998, 18:3327-3335.
14. Steel K.P., Davidson D.R., Jackson I.J. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development 1992, 115:1111-1119.
15. Jones S.M., Johnson K.R., Yu H., Erway L.C., Alagramam K.N., Pollak N., Jones T.A. A quantitative survey of gravity receptor function in mutant mouse strains. J. Assoc. Res. Otolaryngol. 2005, 6:297-310.
16. Nakano Y., Kim S.H., Kim H.M., Sanneman J.D., Zhang Y., Smith R.J., Marcus D.C., Wangemann P., Nessler R.A., Banfi B. A claudin-9-based ion permeability barrier is essential for hearing. PLoS Genet. 2009, 5:e1000610.
17. Xia A., Kikuchi T., Hozawa K., Katori Y., Takasaka T. Expression of connexin 26 and Na, K-ATPase in the developing mouse cochlear lateral wall: functional implications. Brain Res 1999, 846:106-111.
18. Li J., Verkman A.S. Impaired hearing in mice lacking aquaporin-4 water channels. J. Biol. Chem. 2001, 276:31233-31237.
19. Usami S., Takumi Y., Suzuki N., Oguchi T., Oshima A., Suzuki H., Kitoh R., Abe S., Sasaki A., Matsubara A. The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea. Neuroscience 2008, 154:22-28.
20. Abe S., Katagiri T., Saito-Hisaminato A., Usami S., Inoue Y., Tsunoda T., Nakamura Y. Identification of CRYM as a candidate responsible for nonsyndromic, deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am. J. Hum. Genet. 2003, 72:73-82.
21. Huh Y.H., Ryu J.H., Shin S., Lee D.U., Yang S., Oh K.S., Chun C.H., Choi J.K., Song W.K., Chun J.S. Esophageal cancer related gene 4 (ECRG4) is a marker of articular chondrocyte differentiation and cartilage destruction. Gene 2009, 448:7-15.
22. Kujuro Y., Suzuki N., Kondo T. Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc. Natl. Acad. Sci. USA 2010, 107:8259-8264.
23. Delprat B., Ruel J., Guitton M.J., Hamard G., Lenoir M., Pujol R., Puel J.L., Brabet P., Hamel C.P. Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin. Mol. Cell Biol. 2005, 25:847-853.
24. Birkenhager R., Otto E., Schurmann M.J., Vollmer M., Ruf E.M., Maier-Lutz I., Beekmann F., Fekete A., Omran H., Feldmann D., Milford D.V., Jeck N., Konrad M., Landau D., Knoers N.V., Antignac C., Sudbrak R., Kispert A., Hildebrandt F. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat. Genet. 2001, 29:310-314.
25. Ando M., Takeuchi S. Immunological identification of an inward rectifier K+ channel (Kir4.1) in the intermediate cell (melanocyte) of the cochlear stria vascularis of gerbils and rats. Cell Tissue Res. 1999, 298:179-183.
26. Marcus D.C., Wu T., Wangemann P., Kofuji P. KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am. J. Physiol. Cell Physiol. 2002, 282:C403-407.
27. Wangemann P., Itza E.M., Albrecht B., Wu T., Jabba S.V., Maganti R.J., Lee J.H., Everett L.A., Wall S.M., Royaux I.E., Green E.D., Marcus D.C. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med. 2004, 2:30.
28. Singh R., Wangemann P. Free radical stress-mediated loss of Kcnj10 protein expression in stria vascularis contributes to deafness in Pendred syndrome mouse model. Am. J. Physiol. Renal Physiol. 2008, 294:F139-148.